Continuous Pharmaceutical Manufacturing Bill Hitches A Ride With US FDA User Fee Legislation

 
• By Bowman Cox

US legislation could advance new manufacturing platforms for drugs and biologics with academic R&D and workforce development and in turn spur domestic growth.

US Capitol building framed by tulips in spring
legislation has flowered again; may take root

More from Platform Technologies

More from Advanced Technologies